Jay brings more than 20 years of experience in clinical development and medical affairs with a history of successfully bringing new hematology and oncology drugs to market. Most recently he was chief medical officer of Pyxis Oncology. Prior to Pyxis, he served as chief medical officer and senior vice president of ADC Therapeutics, where he led the clinical development of six ADCs for hematologic malignancies and solid tumors. Previously, Jay worked as vice president of U.S. Medical Affairs and chairman of the Global Medical Affairs Oversight Committee at Daiichi Sankyo. Earlier in his career, Jay held various executive roles of increasing responsibility at Wyeth Pharmaceuticals and was a member of the Departments of Medicine and Pediatrics and an Associate Director of the Bone Marrow Transplant Program at the University of Connecticut.
Jay earned his MD and PhD from the Albert Einstein College of Medicine and trained in pediatrics and pediatric hematology and oncology at the UCLA Center for the Health Sciences.